Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Cercek

Showing results (71-80 of 214) with videos related to

Pageof 22
Sort By:
Annals of Surgical Oncology|June 18, 2013
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institutionJohn B Ammori, Nancy E Kemeny, Yuman Fong, et al.
Journal of the American College of Surgeons|February 21, 2017
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival OutcomesJohn M Creasy, Debra A Goldman, Vikas Dudeja, et al.
Annals of Surgical Oncology|November 24, 2020
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 PatientsSepideh Gholami, Susan Stewart, Nancy Kemeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patientsRona Yaeger, Andrea Cercek, Eileen M O'Reilly, et al.
Annals of Surgical Oncology|July 9, 2026
Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic CholangiocarcinomaMisha Armstrong, Hannah Kalvin, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Molecular Characterization of Peritoneal MesotheliomasMichael Offin, Soo-Ryum Yang, Jacklynn Egger, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Journal of Surgical Oncology|November 23, 2017
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potentialLinda M Pak, Nancy E Kemeny, Marinela Capanu, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Pageof 22

Showing results (71-80 of 214) with videos related to

Sort By:
Pageof 22
Annals of Surgical Oncology|June 18, 2013
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institutionJohn B Ammori, Nancy E Kemeny, Yuman Fong, et al.
Journal of the American College of Surgeons|February 21, 2017
Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival OutcomesJohn M Creasy, Debra A Goldman, Vikas Dudeja, et al.
Annals of Surgical Oncology|November 24, 2020
Impact of Primary Tumor Laterality on Adjuvant Hepatic Artery Infusion Pump Chemotherapy in Resected Colon Cancer Liver Metastases: Analysis of 487 PatientsSepideh Gholami, Susan Stewart, Nancy Kemeny, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 16, 2015
Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patientsRona Yaeger, Andrea Cercek, Eileen M O'Reilly, et al.
Annals of Surgical Oncology|July 9, 2026
Investigating Age-Related Differences in Survival Outcomes and Mutation Status of Patients with Intrahepatic CholangiocarcinomaMisha Armstrong, Hannah Kalvin, Mithat Gönen, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 14, 2021
Molecular Characterization of Peritoneal MesotheliomasMichael Offin, Soo-Ryum Yang, Jacklynn Egger, et al.
Clinical Colorectal Cancer|October 15, 2018
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell CancerSebastian Mondaca, Walid K Chatila, David Bates, et al.
Journal of Surgical Oncology|November 23, 2017
Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potentialLinda M Pak, Nancy E Kemeny, Marinela Capanu, et al.
International Journal of Cancer|February 5, 2024
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patientsValerie Lee, Rose Parkinson, Marianna Zahurak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 24, 2019
Romiplostim Treatment of Chemotherapy-Induced ThrombocytopeniaGerald A Soff, Yimei Miao, Gemma Bendheim, et al.
Pageof 22